Thomsen, G. M., Alkaslasi, M., Vit, J., Lawless, G., Godoy, M., Gowing, G., . . . Svendsen, C. N. (2017). Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1(G93A) ALS rat but has adverse side effects. Gene Ther.
Stile di citazione ChicagoThomsen, G M., M. Alkaslasi, J-P Vit, G. Lawless, M. Godoy, G. Gowing, O. Shelest, e C N. Svendsen. "Systemic Injection of AAV9-GDNF Provides Modest Functional Improvements in the SOD1(G93A) ALS Rat but Has Adverse Side Effects." Gene Ther 2017.
Citazione MLAThomsen, G M., et al. "Systemic Injection of AAV9-GDNF Provides Modest Functional Improvements in the SOD1(G93A) ALS Rat but Has Adverse Side Effects." Gene Ther 2017.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.